Kenneth J. Scalapino, MD, FACR, FACP
Chief, Department of Hospital and Specialty Medicine, Portland VA Medical Center
Associate Clinical Professor of Medicine, OHSU
Education and Training
Medical School: University of Pittsburg School of Medicine
IM Residency: University of California, San Francisco
Rheumatology Fellowship: University of California, San Francisco
Prior to joining the OHSU faculty, Dr. Scalapino's research focused on understanding the role of regulatory T cells in autoimmune diseases, in particular in models of systemic lupus erythematosus. Dr. Scalapino's academic activities are now divided between clinician educator and lead physician on a VA funded special project team focused on improving care delivery. He precepts rheumatology fellows and medical residents in the VA outpatient rheumatology continuity clinic and inpatient consult service. He is interested in curriculum development to improve resident training in rheumatology and fellows' effective learning of musculoskeletal radiology. He serves as mentor to rheumatology fellows interested in VA clinical research and quality improvement projects. As lead physician on the VA project team based in the VA's Portland Center for Evaluation of Clinical Services (PCECS), he collaborates with health science researchers, informaticists, and data analysts to optimize the efficiency and quality of healthcare delivery to veterans. His team is currently studying cancer care delivery and is developing systems to improve it which will have wide application including to rheumatology care delivery.
Scalapino KJ, Thomas CR Jr.Paraneoplastic and cancer treatment-related rheumatic disorders.Rheum Dis Clin North Am. 2011 Nov;37(4):ix-x.
Malladi AS, Gratton SB, Stone D, Scalapino KJ, Charles JF. Recurrent adverse psychiatric effects following intra-articular corticosteroid injection. J Clin Rheumatol. 2011 Aug;17(5):284-5.
Boonyaratanakornkit JB, Yue L, Strachan LR, Scalapino KJ, LeBoit PE, Lu Y, Leong SP, Smith JE, Ghadially R.Selection of tumorigenic melanoma cells using ALDH. J Invest Dermatol. 2010 Dec;130(12):2799-808.
Gratton SB, Scalapino KJ, Fye KH.Case of anakinra as a steroid-sparing agent for gout inflammation. Arthritis Rheum. 2009 Sep 15;61(9):1268-70
Scalapino KJ, Daikh DI. Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.PLoS One. 2009 Jun 24;4(6):e6031.